In the last trading session, 15.28 million Oragenics Inc (AMEX:OGEN) shares changed hands as the company’s beta touched 0.95. With the company’s per share price at $1.55 changed hands at -$2.27 or -59.42% during last session, the market valuation stood at $1.11M. OGEN’s last price was a discount, traded about -4777.42% off its 52-week high of $75.60. The share price had its 52-week low at $3.12, which suggests the last value was -101.29% down since then. When we look at Oragenics Inc’s average trading volume, we note the 10-day average is 1.64 million shares, with the 3-month average coming to 220.75K.

Oragenics Inc (AMEX:OGEN) trade information

Instantly OGEN was in red as seen at the end of in last trading. With action -57.06%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -94.78%, with the 5-day performance at -57.06% in the red. However, in the 30-day time frame, Oragenics Inc (AMEX:OGEN) is -56.94% down. Looking at the short shares, we see there were 0.29 million shares sold at short interest cover period of 0.53 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 40.88%.

OGEN Dividends

Oragenics Inc is expected to release its next quarterly earnings report on 2023-May-12.

Oragenics Inc (AMEX:OGEN)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 2.43% of Oragenics Inc shares while 1.32% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.35%. There are 1.32% institutions holding the Oragenics Inc stock share, with GEODE CAPITAL MANAGEMENT, LLC the top institutional holder. As of 2024-06-30, the company held 0.6952% of the shares, roughly 31488.0 OGEN shares worth $32758.0.

RENAISSANCE TECHNOLOGIES LLC holds the second largest percentage of outstanding shares, with 0.4974% or 22528.0 shares worth $23429.0 as of 2024-06-30.